Sinha Uma 4
4 · Eidos Therapeutics, Inc. · Filed Jan 15, 2021
Insider Transaction Report
Form 4
Sinha Uma
Chief Scientific Officer
Transactions
- Sale
Common Stock
2021-01-13$126.39/sh−300$37,917→ 306,525 total - Sale
Common Stock
2021-01-13$121.11/sh−696$84,292→ 315,829 total - Sale
Common Stock
2021-01-13$125.35/sh−2,000$250,700→ 306,825 total - Sale
Common Stock
2021-01-13$122.27/sh−572$69,937→ 315,257 total - Sale
Common Stock
2021-01-13$123.48/sh−1,498$184,971→ 313,759 total - Sale
Common Stock
2021-01-13$124.72/sh−4,934$615,362→ 308,825 total
Footnotes (7)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 Sales Plan adopted by the Reporting Person on August 13, 2020.
- [F2]Represents the weighted average sale price of the shares sold ranging from $120.81 to $121.33 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 through 7.
- [F3]Represents the weighted average sale price of the shares sold ranging from $121.98 to $122.89 per share.
- [F4]Represents the weighted average sale price of the shares sold ranging from $123.01 to $124.00 per share.
- [F5]Represents the weighted average sale price of the shares sold ranging from $124.10 to $125.09 per share.
- [F6]Represents the weighted average sale price of the shares sold ranging from $125.11 to $125.66 per share.
- [F7]Represents the weighted average sale price of the shares sold ranging from $126.30 to $126.57 per share.